Management dilemmas in restarting anticoagulation after gastrointestinal bleeding
Systemic anticoagulants are widely prescribed to prevent and treat thromboembolism, among other indications. A common com-plication of using these agents is gastrointestinal bleeding. While early resumption of anticoagulants after the bleeding has resolved can increase the risk of rebleeding, delayed resumption puts the patient at increased risk of thromboembolic events and mortality. There is limited data on this topic to guide clinicians on resuming anticoagulation after hospitalization for gastrointestinal bleeding and to educate patients regarding the subsequent risks of recurrent gastrointestinal bleeding, thromboembolism, and mortality. The optimal time to resume anticoagulation is also unknown. This review summarizes the existing literature and available data on the commonly encountered dilemma of restarting anticoagulation therapy after hospitalization for gastrointestinal bleeding.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
2022 Developments in Cellular Therapy (Live)
Registration coming soon! 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
2022 Developments in Cellular Therapy (Virtual)
Registration coming soon! 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
A Concerning Trend in Geriatric Pharmacy Merits Evidence-Based Intervention
The effects of polypharmacy on geriatric populations are an emerging concern that merits more exploration. The primary goal of this review was to evaluate the current body of knowledge on polypharmacy and explore the preventive and corrective measures to avoid negative outcomes. Even if a medication has an appropriate indication, polypharmacy in the geriatric population is associated with an increased risk of drug-drug or drug-condition interactions. Recent efforts to prevent polypharmacy include the development of interprofessional teams in clinics dedicated to medication review and reconciliation, deprescription plans aimed to safely discontinue potentially inappropriate medications, and inpatient screening tools that provide prescribing recommendations. In conclusion, polypharmacy affects a high percentage of the geriatric population. Current efforts to address and prevent polypharmacy are ongoing but have not been widely adopted.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance
2023 13th Biennial Bereavement Conference: Expanding the Frontiers of Grief Interventions
Increased societal awareness of the needs of the dying and bereaved requires helpers to utilize up-to-date theoretical principles and innovative treatment techniques to help patients/families prepare for the end of life, navigate events surrounding death, manage acute grief, and adjust after bereavement.
Category
Format
  • Webinar live
Credits
Event date September 22, 2023
2022 Developments in Cellular Therapy Exhibit Registration
The exhibit payment portal will open on July 1, 2022. 
Category
Format
  • Conference / meeting
Credits
Event date November 5, 2022
North Texas Division Allied Health Orientation Review and Attestation
Please click "TAKE COURSE" to beginThank you for your interest in a clinical rotation at Baylor Scott & White Health in our Central Texas Division! Before you can begin your experience with us, you must complete Allied Health Student Orientation.
Category
Format
  • Self-study / Enduring
Credits
2022 Acute and Chronic Pain Management and Opioid Prescribing for Outpatients - [IEM-X]
Acute and Chronic Pain Management and Opioid Prescribing for Outpatients is designed for providers to learn evidence-based treatment of pain, which will result in reduced long-term opioid prescribing and increased use of multimodal, multidisciplinary treatment for chronic pain.
Category
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit
  • Attendance
2022 Fall Pediatric Subspecialty for the Primary Care Provider
This activity is designed to provide the primary care provider with practical clinical information on the recognition and evaluation of specific pediatric subspecialty disorders seen frequently in primary care office settings. 
Category
  • Pediatrics
Format
  • Webinar live
  • Conference / meeting
Credits
  • American Board of Pediatrics (ABP) MOC
  • AMA PRA Category 1 Credit
  • Attendance
Event date September 30, 2022
Optimal Cardiovascular Medical Therapy: Current Guidelines and New Developments
Coronary artery disease is a leading cause of mortality worldwide, and patients with obstructive coronary artery disease require optimal cardiovascular medical therapy along with lifestyle modification for secondary prevention of future cardiac events. Optimal medical therapy includes antiplatelet agents, high-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, aldosterone antagonists, and calcium channel blockers. There are differences in the medical therapy guidelines of the American Heart Association/American College of Cardiology and the European Society of Cardiology. In addition, there are emerging medical therapies that may be added to future guidelines with additional cardiovascular outcome benefits.
Category
  • BUMC Proceedings
Format
  • Journal
Credits
  • American Board of Internal Medicine (ABIM) MOC Part 2
  • AMA PRA Category 1 Credit
  • Attendance

Pages